FTO and metabolic dysfunction-associated steatotic liver disease: Previous studies suggested that FTO gene polymorphisms were commonly correlated with metabolic disorders, especially central obesity, low-density lipoprotein (LDL), insulin resistance, and hypertriglyceridemia [24], which are tightly related to NAFLD [25].